OS Therapies Incorporated is a clinical-stage biopharmaceutical company focused on developing treatments for Osteosarcoma and other solid tumors. Its lead product, OST-HER2, is a Listeria monocytogenes-based cancer immunotherapy targeting HER2-expressing tumors. The company completed a Phase IIb trial showing 75% two-year overall survival versus 40% historical control. It also owns the OST-tADC platform, a next-generation antibody-drug conjugate technology using pH-sensitive silicone linkers.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001213900-26-036629 | EDGAR | 80K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-026238 | EDGAR | 79K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001213900-26-090238 | EDGAR | 28K words |
| 2025-11-14 | 2025-09-30 | 0001213900-25-110829 | EDGAR | 33K words |
| 2025-08-18 | 2025-06-30 | 0001213900-25-077916 | EDGAR | 30K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044336 | EDGAR | 28K words |
| 2024-11-15 | 2024-09-30 | 0001213900-24-098760 | EDGAR | 26K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-069063 | EDGAR | 25K words |
| 2024-05-20 | 2024-03-31 | 0001213900-24-045141 | EDGAR | 23K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-10 | 0001213900-26-098880 | EDGAR | 1K words |
| 2026-09-09 | 0001213900-26-098403 | EDGAR | 12K words |
| 2026-08-21 | 0001213900-26-092651 | EDGAR | 25K words |
| 2026-08-12 | 0001213900-26-088435 | EDGAR | 21K words |
| 2026-08-06 | 0001213900-26-086150 | EDGAR | 6K words |
| 2026-07-29 | 0001213900-26-082876 | EDGAR | 1K words |
| 2026-04-02 | 0001213900-26-039529 | EDGAR | 23K words |
| 2026-03-31 | 0001213900-26-037476 | EDGAR | 1K words |
| 2026-03-06 | 0001213900-26-024726 | EDGAR | 22K words |
| 2026-02-13 | 0001213900-26-016408 | EDGAR | 1K words |
65 total filings indexed. 46 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001795091 |
| Ticker | OSTX |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ostherapies.com |
| Listed | 2024-08-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/OSTX (~200 tokens, structured JSON with cryptographic provenance)